Annual CFI
$10.22 M
+$25.00 M+169.19%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual cash flow from investing activities is $10.22 million, with the most recent change of +$25.00 million (+169.19%) on December 31, 2023.
- During the last 3 years, GANX annual CFI has risen by +$10.24 million (+49247.60%).
- GANX annual CFI is now at all-time high.
Performance
GANX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
-$2.00 M-100.00%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly cash flow from investing activities is $0.00, with the most recent change of -$2.00 million (-100.00%) on September 30, 2024.
- Over the past year, GANX quarterly CFI has dropped by -$3.14 million (-100.00%).
- GANX quarterly CFI is now -100.00% below its all-time high of $3.14 million, reached on December 31, 2023.
Performance
GANX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$8.16 M
-$1.93 M-19.11%
September 30, 2024
Summary
- As of February 12, 2025, GANX TTM cash flow from investing activities is $8.16 million, with the most recent change of -$1.93 million (-19.11%) on September 30, 2024.
- Over the past year, GANX TTM CFI has dropped by -$2.06 million (-20.15%).
- GANX TTM CFI is now -26.69% below its all-time high of $11.13 million, reached on March 31, 2024.
Performance
GANX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GANX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +169.2% | -100.0% | -20.1% |
| 3 y3 years | +10000.0% | +100.0% | +8765.4% |
| 5 y5 years | +10000.0% | +100.0% | +8765.4% |
GANX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +169.2% | -100.0% | +100.0% | -26.7% | +154.6% |
| 5 y | 5-year | at high | +169.2% | -100.0% | +100.0% | -26.7% | +154.6% |
| alltime | all time | at high | +169.2% | -100.0% | +100.0% | -26.7% | +154.6% |
Gain Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $8.16 M(-19.1%) |
| Jun 2024 | - | $2.00 M(-33.7%) | $10.09 M(-9.4%) |
| Mar 2024 | - | $3.02 M(-3.9%) | $11.13 M(+8.9%) |
| Dec 2023 | $10.22 M(-169.2%) | $3.14 M(+62.9%) | $10.22 M(+41.7%) |
| Sep 2023 | - | $1.93 M(-36.7%) | $7.21 M(+36.8%) |
| Jun 2023 | - | $3.05 M(+44.5%) | $5.27 M(-141.7%) |
| Mar 2023 | - | $2.11 M(+1474.7%) | -$12.66 M(-14.3%) |
| Dec 2022 | -$14.77 M(>+9900.0%) | $133.80 K(-1273.7%) | -$14.77 M(-1.0%) |
| Sep 2022 | - | -$11.40 K(-99.9%) | -$14.92 M(-0.1%) |
| Jun 2022 | - | -$14.89 M(>+9900.0%) | -$14.94 M(>+9900.0%) |
| Mar 2022 | - | -$7800.00 | -$73.50 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$94.20 K(+352.9%) | - | - |
| Dec 2021 | - | -$11.10 K(-65.4%) | -$94.20 K(-3.6%) |
| Sep 2021 | - | -$32.10 K(+42.7%) | -$97.70 K(+45.8%) |
| Jun 2021 | - | -$22.50 K(-21.1%) | -$67.00 K(+50.6%) |
| Mar 2021 | - | -$28.50 K(+95.2%) | -$44.50 K(+112.9%) |
| Dec 2020 | -$20.80 K(+51.8%) | - | - |
| Dec 2020 | - | -$14.60 K(+942.9%) | -$20.90 K(+231.7%) |
| Sep 2020 | - | -$1400.00(<-9900.0%) | -$6300.00(+28.6%) |
| Jun 2020 | - | $0.00(-100.0%) | -$4900.00(0.0%) |
| Mar 2020 | - | -$4900.00 | -$4900.00 |
| Dec 2019 | -$13.70 K(+71.3%) | - | - |
| Dec 2018 | -$8000.00 | - | - |
FAQ
- What is Gain Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Gain Therapeutics?
- What is Gain Therapeutics annual CFI year-on-year change?
- What is Gain Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Gain Therapeutics?
- What is Gain Therapeutics quarterly CFI year-on-year change?
- What is Gain Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Gain Therapeutics?
- What is Gain Therapeutics TTM CFI year-on-year change?
What is Gain Therapeutics annual cash flow from investing activities?
The current annual CFI of GANX is $10.22 M
What is the all time high annual CFI for Gain Therapeutics?
Gain Therapeutics all-time high annual cash flow from investing activities is $10.22 M
What is Gain Therapeutics annual CFI year-on-year change?
Over the past year, GANX annual cash flow from investing activities has changed by +$25.00 M (+169.19%)
What is Gain Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of GANX is $0.00
What is the all time high quarterly CFI for Gain Therapeutics?
Gain Therapeutics all-time high quarterly cash flow from investing activities is $3.14 M
What is Gain Therapeutics quarterly CFI year-on-year change?
Over the past year, GANX quarterly cash flow from investing activities has changed by -$3.14 M (-100.00%)
What is Gain Therapeutics TTM cash flow from investing activities?
The current TTM CFI of GANX is $8.16 M
What is the all time high TTM CFI for Gain Therapeutics?
Gain Therapeutics all-time high TTM cash flow from investing activities is $11.13 M
What is Gain Therapeutics TTM CFI year-on-year change?
Over the past year, GANX TTM cash flow from investing activities has changed by -$2.06 M (-20.15%)